FcRn inhibitors for myasthenia gravis

Laura M White, Fiona J Clay, Anne-Marie Forbes, Ryan Yann Shern Keh, James B Lilleker, Jennifer Spillane, Karen Storms, Katherine C Dodd, Jon Sussman

Open source

DOI
10.1002/14651858.cd016097
Published
2025-08-22
Container
Cochrane Database of Systematic Reviews
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/14651858.cd016097,
  title = {FcRn inhibitors for myasthenia gravis},
  author = {Laura M White and Fiona J Clay and Anne-Marie Forbes and Ryan Yann Shern Keh and James B Lilleker and Jennifer Spillane and Karen Storms and Katherine C Dodd and Jon Sussman},
  year = {2025},
  journal = {Cochrane Database of Systematic Reviews},
  doi = {10.1002/14651858.cd016097},
  url = {https://doi.org/10.1002/14651858.cd016097}
}

RIS

TY  - JOUR
TI  - FcRn inhibitors for myasthenia gravis
AU  - Laura M White
AU  - Fiona J Clay
AU  - Anne-Marie Forbes
AU  - Ryan Yann Shern Keh
AU  - James B Lilleker
AU  - Jennifer Spillane
AU  - Karen Storms
AU  - Katherine C Dodd
AU  - Jon Sussman
PY  - 2025
JO  - Cochrane Database of Systematic Reviews
DO  - 10.1002/14651858.cd016097
UR  - https://doi.org/10.1002/14651858.cd016097
ER  - 

APA

White, L. M., Clay, F. J., Forbes, A., Keh, R. Y. S., Lilleker, J. B., Spillane, J., Storms, K., Dodd, K. C., & Sussman, J. (2025). FcRn inhibitors for myasthenia gravis. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd016097

Source records